Quarterly report pursuant to Section 13 or 15(d)

Redeemable Preferred Stock and Stockholders' Equity (Tables)

v3.23.2
Redeemable Preferred Stock and Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Summary of Income Statement Classification of Compensation Expense

The following table summarizes the statement of operations classification of compensation expense associated with share-based payments (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Cost of revenue

 

$

5

 

 

$

93

 

 

$

23

 

 

$

113

 

Sales and marketing

 

 

105

 

 

 

213

 

 

 

302

 

 

 

312

 

General and administrative

 

 

(25

)

 

 

109

 

 

 

405

 

 

 

151

 

Engineering and development

 

 

(1

)

 

 

475

 

 

 

45

 

 

 

524

 

Total

 

$

84

 

 

$

890

 

 

$

775

 

 

$

1,100

 

Summary of Option Activity

A summary of option activity for the six months ended June 30, 2023 is as follows (in thousands, except per share data):

 

 

 

 

 

 

Weighted

 

 

Weighted
Average
Remaining

 

 

 

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Aggregate

 

 

 

Shares

 

 

Exercise
Price

 

 

Term
(Years)

 

 

Intrinsic
Value (1)

 

Options outstanding as of December 31, 2022

 

 

1

 

 

$

7,494.72

 

 

 

5.8

 

 

$

 

Forfeited, cancelled, or expired (2)

 

 

 

 

$

23,791.67

 

 

 

 

 

$

 

Options outstanding as of June 30, 2023

 

 

1

 

 

$

7,419.60

 

 

 

5.3

 

 

$

 

Options exercisable as of June 30, 2023

 

 

1

 

 

$

7,569.48

 

 

 

5.2

 

 

$

 

Vested options expired during the period ended June 30, 2023

 

 

 

 

$

 

 

 

 

 

 

 

Summary of Unvested Stock Option Activity

A summary of unvested stock option activity for the six months ended June 30, 2023 is as follows (in thousands, except per share data):

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average Grant

 

 

 

Shares (1)

 

 

Date Fair Value

 

Unvested options as of December 31, 2022

 

 

 

 

$

1,438.11

 

Vested

 

 

 

 

$

1,595.99

 

Unvested options as of June 30, 2023

 

 

 

 

$

1,366.14

 

 

(1)
Rounded to less than 1,000 shares as adjusted for the 2023 reverse stock split.
Fair Value Disclosures Related to Grants, Exercises and Vesting Options

Fair value disclosures related to grants, exercises and vested options are as follows (in thousands, except per share amounts):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Total fair value of stock options vested during the period

 

$

4

 

 

$

10

 

 

$

10

 

 

$

24

 

 

Stock Option Activity

There were no option grants or exercises during the three and six months ended June 30, 2023 and 2022.

Summary of Unvested Restricted Stock Units

A summary of unvested RSU activity for the six months ended June 30, 2023 is as follows (in thousands, except per share amounts):

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested RSUs as of December 31, 2022

 

 

4

 

 

$

526.80

 

Granted

 

 

57

 

 

$

11.46

 

Vested

 

 

(9

)

 

$

158.09

 

Forfeited or cancelled

 

 

 

 

$

1,501.38

 

Unvested RSUs as of June 30, 2023

 

 

52

 

 

$

28.63

 

Summary of Warrant Activity

A summary of the share equivalent of warrant activity for the six months ended June 30, 2023 is as follows (in thousands, except exercise price amounts):

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

Shares

 

 

Exercise
Price

 

Warrants outstanding as of December 31, 2022

 

 

21

 

 

$

656.28

 

Granted or Issued

 

 

427

 

 

$

953.07

 

Exercised

 

 

(186

)

 

$

501.73

 

Warrants outstanding as of June 30, 2023

 

 

262

 

 

$

1,248.63

 

Warrants exercisable as of June 30, 2023

 

 

262

 

 

$

1,248.63

 

Vested warrants expired during the period
 ended June 30, 2023

 

 

 

 

$